Vitamin D in the treatment of cardiorenal syndrome in patients with chronic nephropathy
AN Kharlamov, AN Perrish, G IaL, R Kh, I EIu - Kardiologiia, 2012 - europepmc.org
AN Kharlamov, AN Perrish, G IaL, R Kh, I EIu
Kardiologiia, 2012•europepmc.org… To determine place of vitamin D in prevention and treatment of cardiorenal syndrome (CRS)
and chronic allograft nephropathy (CAN) in the aspect of myocardial and renal reparation. …
In Russia and the Netherlands we included in a randomized placebo controlled study 120
vitamin D deficient [25(OH) vitamin D<40 mol/l] recipients of asystolic and cadaveric donors.
Patients were divided in 4 groups: paricalcitol (2-4 g/day) group (n=28), calcitriol (1-6 g/day
orally) group (n=28), diet (1200-1800 IU/day of vitamin D with multivitamins and from …
and chronic allograft nephropathy (CAN) in the aspect of myocardial and renal reparation. …
In Russia and the Netherlands we included in a randomized placebo controlled study 120
vitamin D deficient [25(OH) vitamin D<40 mol/l] recipients of asystolic and cadaveric donors.
Patients were divided in 4 groups: paricalcitol (2-4 g/day) group (n=28), calcitriol (1-6 g/day
orally) group (n=28), diet (1200-1800 IU/day of vitamin D with multivitamins and from …
Aim
To determine place of vitamin D in prevention and treatment of cardiorenal syndrome (CRS) and chronic allograft nephropathy (CAN) in the aspect of myocardial and renal reparation.
europepmc.org
以上显示的是最相近的搜索结果。 查看全部搜索结果